Gregory M. Glenn
2020
In 2020, Gregory M. Glenn earned a total compensation of $24.9M as President, Research and Development at Novavax, a 1,229% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $362,582 |
|---|---|
| Option Awards | $22,859,741 |
| Salary | $483,443 |
| Stock Awards | $1,206,210 |
| Other | $11,400 |
| Total | $24,923,376 |
Glenn received $22.9M in option awards, accounting for 92% of the total pay in 2020.
Glenn also received $362.6K in non-equity incentive plan, $483.4K in salary, $1.2M in stock awards and $11.4K in other compensation.
Rankings
In 2020, Gregory M. Glenn's compensation ranked 138th out of 13,090 executives tracked by ExecPay. In other words, Glenn earned more than 98.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 138 out of 13,090 | 99th |
Division Manufacturing | 40 out of 5,621 | 99th |
Major group Chemicals And Allied Products | 9 out of 2,254 | 100th |
Industry group Drugs | 8 out of 1,954 | 100th |
Industry Biological Products, Except Diagnostic Substances | 3 out of 411 | 99th |
Pay ratio
| Gregory M. Glenn's Pay | $24,923,376 |
|---|---|
| Median Employee's Pay | $400,755 |
| Pay Ratio | 62to 1 |
In 2020, the annual total compensation of Gregory M. Glenn was $24,923,376.
The annual total compensation of the median employee at Novavax was $400,755.
The ratio of Gregory M. Glenn's pay to the pay of median employee was therefore 62 to one.
Source: SEC filing on May 3, 2021.
Glenn's colleagues
We found four more compensation records of executives who worked with Gregory M. Glenn at Novavax in 2020.